SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Oncolytics Biotech Reports ~15-Month Median Response Duration in Anal Cancer Study

The company reported that all responding patients in GOBLET Cohort 4 survived beyond one year.

ONCY

Related stories